Alnylam Pharmaceuticals ALNY 161.08 1.19 0.74%
Expected move
November 04, 2026 close · $161.08| Horizon | Expected move | Typical range | 2 in 3 closes | 9 in 10 closes |
|---|---|---|---|---|
| Next session | ±2.8% ±$4.53 | $156.55 – $165.61 | $155.65 – $166.51 | $151.37 – $170.79 |
| 2 sessions | ±3.9% ±$6.30 | $154.78 – $167.38 | $153.44 – $168.72 | $147.50 – $174.66 |
| 3 sessions | ±4.9% ±$7.93 | $153.15 – $169.01 | $151.62 – $170.54 | $144.20 – $177.96 |
| 1 week | ±6.3% ±$10.07 | $151.01 – $171.15 | $148.76 – $173.40 | $139.62 – $182.54 |
| 2 weeks | ±8.8% ±$14.14 | $146.94 – $175.22 | $143.59 – $178.57 | $130.91 – $191.25 |
| 3 weeks | ±10.6% ±$17.03 | $144.05 – $178.11 | $139.91 – $182.25 | $125.11 – $197.05 |
| 1 month | ±12.2% ±$19.59 | $141.49 – $180.67 | $136.63 – $185.53 | $119.55 – $202.61 |
Earnings: priced against what happened
Average implied move
±7.37%
Average actual move
2.34%
Beyond the implied move
0 / 2
Median IV change
-30.00%
| Reaction session | Implied | Actual | Used | ATM IV before → after |
|---|---|---|---|---|
| February 12, 2026 | ±7.76% | -4.28% | 0.55× | — |
| February 13, 2025 | ±6.97% | -0.40% | 0.06× | 54.3% → 36.0% |